VitaNova Life Sciences Corp
VitaNova Life Sciences Corp is a Nevada-incorporated U.S. company that operates through two main lines of business: business consulting services and the marketing and supply of healthcare products. Its healthcare offering includes anti-aging and dietary supplement products, along with health consultation services, sold to customers in the United States and selected international markets.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueManagement, accounting, and finance advisory services for domestic and international clients.
Anti-aging and dietary supplement products marketed and supplied through distributor and direct channels.
Personalized health advice and nutrition/wellness planning tied to supplement sales.
Products
Reported · share of revenue- Dietary Supplement Products64.4 %
- Sale of Food Products35.1 %
- Consulting Service Income0.5 %
Source: 10-K FY2026, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
The company serves domestic and international customers that need business consulting, accounting, and finance support, as well as buyers of healthcare and dietary supplement products. Reported customer types include restaurants, retailers, and individual consumers, with additional sales through distributor channels. Its healthcare offering also targets customers seeking personalized health consultation and wellness planning.
Businesses and other clients buying management, accounting, and finance advisory services.
Restaurants and retailers purchasing healthcare products through distribution channels.
End customers buying anti-aging and dietary supplement products directly.
Consumers seeking personalized health advice and wellness plans tied to supplement use.
Strategy
The company is building a two-segment model that combines consulting services with healthcare product marketing and supply. Its stated priorities are to expand product offerings, use multi-channel sales, and build alliances with hospitals, clinics, and health management institutions to support distribution and credibility. It also seeks international expansion to reduce dependence on any single market.
Broader product availability can increase customer reach and support the healthcare segment.
Partnerships with healthcare institutions can improve credibility and access to buyers.
International sales reduce reliance on a single customer market and broaden demand sources.
Geography
Q1/2026The company sells to customers in the United States and international markets, with reported major customer locations including Hong Kong and China. Its revenue base is therefore cross-border and exposed to demand shifts in both U.S. and Asia-linked customer markets. The business model relies on distributor channels and direct sales rather than a single domestic market.
Risks
The business faces start-up-stage execution risk, limited operating history, and dependence on additional capital to support growth. It also operates in competitive consumer health and consulting markets where channel execution, product acceptance, and customer concentration can materially affect results. Lack of insurance and reliance on a small operating base increase the impact of legal, operational, and financing shocks.
The company has only a short track record, so demand, margins, and execution are unproven.
Exposure: Company-wide
Growth and working capital needs may require external funding, which can dilute shareholders or limit operations.
Exposure: Company-wide
The company states it does not maintain insurance, increasing downside from claims or litigation.
Exposure: Legal and operational
A meaningful share of revenue is tied to a few markets, especially Hong Kong, China, and the U.S.
Supplements and anti-aging products face many substitutes and require marketing spend and channel access.
Exposure: Healthcare segment
Accounting
Judgemental itemsThe company uses different recognition patterns for services and products, affecting quarterly comparability.
Impact: Consulting over time; healthcare products at point in time
Revenue is recorded when control transfers, but cash collection timing may lag and affect working capital.
Impact: Receivables and cash flow
Product-based revenue requires inventory and supplier prepayments, which can create valuation and obsolescence risk.
Impact: Cost of revenue and working capital
Tax expense can vary with small changes in pretax results and jurisdictional mix.
Impact: Net income volatility
Similar listed companies
Publicly listed companies with a comparable business focus.
MetaVia Inc.
MTVA · Pharmaceutical Preparations
Eva Live Inc
GOAI · Services-Computer Programming, Data Processing, Etc.
Eva Live Inc is a U.S.-based digital marketing and media monetization company that operates an ad-tech platform and related campaign services.
LivaNova PLC
LIVN · Electromedical & Electrotherapeutic Apparatus
LivaNova PLC is a medical technology company focused on therapies for cardiac and neurological conditions.
Goldenwell Biotech, Inc.
GWLL · Food and Kindred Products
Veeva Systems Inc
VEEV · Services-Prepackaged Software
Veeva Systems is a U.S.-based software company focused on cloud applications, data products, and consulting services for the global life sciences industry.
Viva Wine Group
VIVA · Consumer Staples
Viva Wine Group is a prominent European wine group that specializes in developing, marketing, and selling a diverse range of quality wines.
Last updated: 29/04/2026